Sensei Biotherapeutics Inc (SNSE) Insider Trading
- $3,135,907.49
- $5,650,708.10
- Sept. 11, 2023
- Cambrian Biopharma Inc
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| March 22, 2021 | Major Shareholder | 2,183 | $15.02 | Buy | $32,788.66 | |
| March 18, 2021 | Major Shareholder | 817 | $15.25 | Buy | $12,459.25 | |
| March 8, 2021 | Director | 1,000 | $15.25 | Buy | $15,250.00 | |
| March 5, 2021 | Major Shareholder | 8,000 | $13.75 | Buy | $110,000.00 | |
| Feb. 23, 2021 | Director | 20,300 | $17.79 | Buy | $361,137.00 | |
| Feb. 22, 2021 | Major Shareholder | 9,802 | $18.88 | Buy | $185,061.76 |
Insiders are both buying and selling Sensei Biotherapeutics Inc stock.
The insider traders at Sensei Biotherapeutics Inc are: Cambrian Biopharma Inc, James Peyer, Robert Hamilton Pierce, Apeiron Investment Group Ltd., John Celebi, and Thomas G Ricks
The most active insider trader at Sensei Biotherapeutics Inc is Cambrian Biopharma Inc with 28 trades.
Apeiron Investment Group Ltd. has sold the most Sensei Biotherapeutics Inc stock with a total value of $10,875,648.76.
Cambrian Biopharma Inc has bought the most Sensei Biotherapeutics Inc stock with a total value of $1,608,080.07.
The most recent insider trade for Sensei Biotherapeutics Inc was on Sept. 11, 2023.
The single biggest insider buy for Sensei Biotherapeutics Inc was from James Peyer with a total value of $361,137.00 on Feb. 23, 2021.
The single biggest insider sell for Sensei Biotherapeutics Inc was from Apeiron Investment Group Ltd. with a total value of $5,437,824.38 on June 1, 2023.